参考文献
1: Wu H, Yang J, Su EM, Li L, Zhao C, Yang X, Gao Z, Pan M, Sun P, Sun W, Jiang
Y, Su X. Lipoxin A4 and platelet activating factor are involved in E. coli or
LPS-induced lung inflammation in CFTR-deficient mice. PLoS One. 2014 Mar
26;9(3):e93003. doi: 10.1371/journal.pone.0093003. eCollection 2014. PubMed PMID:
24671173; PubMed Central PMCID: PMC3966846.
2: Loo TW, Bartlett MC, Shi L, Clarke DM. Corrector-mediated rescue of
misprocessed CFTR mutants can be reduced by the P-glycoprotein drug pump. Biochem
Pharmacol. 2012 Feb 1;83(3):345-54. doi: 10.1016/j.bcp.2011.11.014. Epub 2011 Nov
28. PubMed PMID: 22138447.
3: Robert R, Carlile GW, Pavel C, Liu N, Anjos SM, Liao J, Luo Y, Zhang D, Thomas
DY, Hanrahan JW. Structural analog of sildenafil identified as a novel corrector
of the F508del-CFTR trafficking defect. Mol Pharmacol. 2008 Feb;73(2):478-89.
Epub 2007 Nov 1. PubMed PMID: 17975008.
